BIRCH team
Rhea Coler Seattle Children's COVID-19 coronavirus Vaccine
April 09, 2020 | Health News

First Vaccine Trial for SARS-CoV-2 (includes Rhea Coler)

The Coler Lab at Seattle Children’s Research Institute is using their expertise to support the clinical trial of an experimental coronavirus vaccine funded by National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health. The trial is being conducted at the Kaiser Permanente Washington Health Research Institute in Seattle, part of NIAID’s Infectious Diseases Clinical Research Consortium.

Women of Color UW Teaching and Learning Symposium Students
April 09, 2020 | Department News

Women of Color in Global Health Group Presents Research on Equity, Community, Leadership, and Resilience at UW Symposium

As the world adapts to the circumstances surrounding the COVID-19 pandemic, countless conferences, seminars, and other gatherings have gone completely virtual. One such event, the UW Teaching & Learning Symposium, was held online on April 6, 2020. This symposium, in its 16th year of existence, brings faculty, staff, and students from all three UW campuses to share their experiences around teaching, learning, and research.

COVID-19 coronavirus Heart Ventilators School of Public Health
April 07, 2020 | Department News

Study Shows Link Between COVID-19 and Heart Issues, Poor Outcomes for Patients on Ventilators (UW School of Public Health - Study led by Matt Arentz)

A University of Washington study provides some of the first details of 21 critically ill patients with the coronavirus disease 2019 (COVID-19) in the United States, most of whom were linked to exposures at a nursing home at the center of the country’s COVID-19 outbreak early on in the global crisis.

BIRCH team
COVID-19 PEP Prevention ICRC Ruanne Barnabas
April 01, 2020 | Health News

Does Antimalarial Drug Prevent COVID-19? New DGH Study Seeks Answers (Ruanne Barnabas, ICRC)

The benefits of hydroxychloroquine being investigated in multi-site clinical trial launching in April

Researchers are investigating whether hydroxychloroquine – a commonly used anti-malarial and autoimmune drug – can prevent COVID-19.

A multi-site clinical trial, led by the University of Washington Department of Global Health/International Clinical Research Center (ICRC)  in collaboration with NYU Grossman School of Medicine, aims to definitively determine whether hydroxychloroquine can prevent transmission in people exposed to the virus.

Match Day UW Medicine School of Medicine MPH COVID-19
April 01, 2020 | Department News

Match Day Goes Virtual (UW Medicine - Quotes August Longino)

The COVID-19 crisis has brought a whirlwind of changes that have impacted everyone in our community — including this year’s graduating class of medical students at UW School of Medicine. 

In the last few weeks, the students were pulled from their clinical rotations early.

Then, the difficult and unprecedented decision was made to hold the School’s Match Day ceremony online.

Paul Drain Research grant HIV PrEP
March 30, 2020 | Department News

New Research Aimed at Promoting Better Patient Adherence to HIV Medications

Paul Drain—an Associate Professor in the Department of Global Health, Medicine and Epidemiology at the University of Washington—and his research team have received a new grant from the CoMotion Innovation Gap Fund, a program intended to help bridge the gap between academic research grants and the level of development needed to obtain investment. Drain’s project is titled “Rapid test for measuring adherence to antiretroviral therapy and pre-exposure prophylaxis”.  

BIRCH team
COVID-19 coronavirus IHME Hospitals
March 26, 2020 | Health News

US Hospitals Could Be Overwhelmed in the Second Week of April (IHME)

In a forecast based on new data analyses, researchers find demand for ventilators and beds in US hospital intensive care units (ICUs) will far exceed capacity for COVID-19 patients as early as the second week of April. Deaths related to the current wave of COVID-19 in the US are likely to persist into July, even assuming people protect themselves and their communities by strongly adhering to social distancing measures and by taking other precautions advised by public health officials. 

Center for Aids Research (CFAR) International Infrastructure Awards John Kinuthia Geoffrey Gottlieb
March 26, 2020 | Department News

DGH Researchers Receive CFAR International Infrastructure Awards

The University of Washington/Fred Hutch Center for AIDS Research (CFAR) recently announced the recipients of their International Infrastructure Awards. Geoffrey Gottlieb (Adjunct Professor of Global Health), John Kinuthia (Affiliate Associate Professor), Rose Bosire (Clinical Research Scientist/Global Health Fellow), and Sylvia LaCourse (Assistant Professor) each received awards.

Pages